Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy

被引:36
|
作者
von Gruenigen, Vivian E. [1 ]
Frasure, Heidi E. [2 ]
Kavanagh, Mary Beth [3 ]
Lerner, Edith [3 ]
Waggoner, Steven E. [2 ]
Courneya, Kerry S. [4 ]
机构
[1] Summa Hlth Syst Akron City Hosp, Akron, OH USA
[2] Univ Hosp, Case Med Ctr, Cleveland, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Univ Alberta, Edmonton, AB, Canada
关键词
Ovarian cancer; Lifestyle; Nutrition; Physical activity; Quality of life; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; FUNCTIONAL ASSESSMENT; RANDOMIZED-TRIAL; FATIGUE; SURVIVAL; EXERCISE; ASSOCIATIONS; VALIDITY; EVENTS;
D O I
10.1016/j.ygyno.2011.04.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. This study aimed to assess the feasibility of a lifestyle intervention for promoting physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer. Methods. Patients were enrolled post-operatively and received PA and nutrition counseling, at every chemotherapy visit for six cycles. Quality of life (QoL) was measured with the Functional Assessment of Cancer Therapy (FACT-G), PA with the Leisure Score Index (LSI), dietary intake with 3-day food records, and symptom severity/distress by the Memorial Symptom Assessment Scale (MSAS). Pedometer step count was collected during chemotherapy cycles. Results. Recruitment was 73% with 27 patients enrolled. Mean [95% confidence interval] change in minutes of PA from cycle #3 to following cycle #6 was 61 min [-3, 120] p = 0.063, and from baseline to after cycle #6 was 73 min [-10, 15]; p = 0.082. Mean change in total fruit and vegetable consumption between baseline and during chemotherapy was 0.56 [-0.09, 0.64]; p = 0.090. FACT-G increased from 75.4 at baseline to 77.6 during chemotherapy and 83.9 following chemotherapy (p = 0.001 for change from baseline to post-chemotherapy). Mean total MSAS score was 20.6 at baseline, 26.6 at cycle #3 and decreased to 17.0 following chemotherapy (p = 0.01 comparison of cycle #3 and following chemotherapy). Increased moderate to strenuous PA was correlated with higher physical well-being during chemotherapy (r = 0.48, p = 0.037). Conclusions. Lifestyle counseling during adjuvant chemotherapy for ovarian cancer is feasible and may improve PA and diet quality. Randomized controlled trials examining the effects of lifestyle counseling on quality of life and treatment outcomes in ovarian cancer patients are warranted. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 50 条
  • [41] Energy balance in early breast cancer patients receiving adjuvant chemotherapy
    Harvie, MN
    Campbell, IT
    Baildam, A
    Howell, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (03) : 201 - 210
  • [42] LYMPHOCYTE CYTOGENETICS IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
    STEPHAN, EJ
    TATTERSALL, MHN
    BAKER, RSU
    GILLIES, CB
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (04) : 434 - 434
  • [43] Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Hurria, A
    Brogan, K
    Panageas, KS
    Pearce, C
    Norton, L
    Jakubowski, A
    Zauderer, M
    Howard, J
    Hudis, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (02) : 151 - 156
  • [44] Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study
    Bourke, Liam
    Doll, Helen
    Crank, Helen
    Daley, Amanda
    Rosario, Derek
    Saxton, John M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (04) : 647 - 657
  • [45] Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study
    Fabbro, Michel
    Jacot, William
    Jarlier, Marta
    Guiu, Severine
    D'Hondt, Veronique
    Pouderoux, Stephane
    Champoiral, Patrice
    Janiszewski, Chloe
    Nickles, Isabelle
    CANCER REPORTS, 2023, 6 (01)
  • [46] Influence of preoperative chemoradiotherapy to the feasibility of adjuvant chemotherapy in pancreatic cancer patients
    Eguchi, Hidetoshi
    Tomihara, Hideo
    Iwagami, Yoshifumi
    Akita, Hirofumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Gotoh, Kunihito
    Kobayashi, Shogo
    Mori, Masaki
    Doki, Yuichiro
    CANCER SCIENCE, 2018, 109 : 1400 - 1400
  • [47] A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
    Schlappe, Brooke A.
    Zhou, Qin C.
    O'Cearbhaill, Roisin
    Iasonos, Alexia
    Soslow, Robert A.
    Abu-Rustum, Nadeem R.
    Mueller, Jennifer J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (05) : 904 - 909
  • [48] Palliative cancer patient's experiences of participating in a lifestyle intervention study while receiving chemotherapy
    Perez-Garcia, Esteban
    ENFERMERIA CLINICA, 2016, 26 (02): : 149 - 151
  • [49] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Lee, J. Y.
    Nam, E. J.
    Kim, S. K.
    Kim, S. W.
    Kim, Y. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 662 - 662
  • [50] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Eoh, K. J.
    Lee, I.
    Lee, J. Y.
    Nam, E. J.
    Kim, S.
    Kim, S. W.
    Kim, Y. T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 101 - 102